6 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Unknown 6 |
Follow Basiliximab: new trials by email Literature Review of Basiliximab trials Research Report on Basiliximab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement Basiliximab, Vedolizumab - Safety and Efficacy | Phase 4 | Unknown | The First Affiliated Hospital of Soochow University | 45 | 2022-08-01 | 2023-10-04 |
| Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD Ruxolitinib - Safety and Efficacy | Phase 4 | Unknown | The First Affiliated Hospital of Soochow University | 50 | 2020-12-15 | 2021-08-25 |
| Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients Basiliximab 20 milligram [Simulect], Normal Saline - Kidney Transplantation | Phase 4 | Unknown | King Faisal Specialist Hospital & Research Center | 140 | 2020-09-01 | 2021-02-18 |
| Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation Antithymocyte Immunoglobulin (Rabbit), Interleukin 2 Receptor Antagonist - Kidney Transplant Rejection | Phase 4 | Unknown | University of Khartoum | 300 | 2018-03-21 | 2019-01-03 |
| Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major Busulfan, Cyclophosphamide, Fludarabine - Thalassemia Major | Phase 4 | Unknown | First Affiliated Hospital of Guangxi Medical University | 30 | 2017-04-01 | 2017-05-31 |
| Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation cyclosporine, Everolimus - Renal Transplantation | Phase 4 | Unknown | University Hospital, Antwerp | 152 | 2008-10-01 | 2009-05-18 |
Neoplasms (1) · Rejection, Psychology (1) · beta-Thalassemia (1)
The First Affiliated Hospital of Soochow University (2) · First Affiliated Hospital of Guangxi Medical University (1) · King Faisal Specialist Hospital & Research Center (1) · University Hospital, Antwerp (1) · University of Khartoum (1)
China (3) · Belgium (1) · Saudi Arabia (1) · Sudan (1)
Xuefeng He, doctor (2) · Jean-Louis Bosmans, MD/PhD (1) · Sarra Elamin, MD (1) · Yongrong Lai, MD (1)